Pro-Resolution Pathway Stimulators for Skin Inflammation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current skincare products often fail to effectively address inflammatory skin conditions as they do not adequately target the biological pathways contributing to inflammation, leading to inefficiencies in reducing inflammation and promoting resolution.
Innovation Solution
Development of a composition containing Pro-Resolution Pathway Stimulators, such as Inflammatory Metabolite Inhibitors and Pro-Resolving Activators, which are identified through screening processes that quantify their ability to decrease inflammatory metabolites and increase pro-resolving lipid mediators, thereby normalizing skin conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional anti-inflammatory ingredients are used in skincare products, then the products can be formulated with common ingredients, but they fail to effectively target biological pathways contributing to inflammation
Solution Approach 1:
The patent changes the parameter of ingredient selection from traditional anti-inflammatory compounds to specific pro-resolution pathway stimulators. By identifying and formulating with ingredients that specifically stimulate pro-resolution lipid mediator production (such as resolvins, protectins, lipoxins), the product effectively targets the resolution phase of inflammation. This parameter change transforms the approach from generic anti-inflammatory to pathway-specific pro-resolution therapy.
2Reliability
If products contain ingredients without impact on reactive pathways, then formulation is simpler, but they are not effective in treating irritated or inflamed skin
Solution Approach 1:
The patent introduces pro-resolution pathway stimulators as intermediary substances that mediate between the applied cosmetic product and the skin's inflammatory response. These ingredients act as mediators that specifically stimulate the skin's endogenous pro-resolution lipid mediator pathways. By using these intermediary substances, the formulation bridges the gap between external application and internal biological pathway activation, achieving effective inflammation resolution.
3Measurement precision
If screening processes measure lipid mediators in human test subjects, then individual response can be assessed, but scientific accuracy is reduced due to individual differences in sensitivity and immune response
Solution Approach 1:
The patent extracts the measurement process from human test subjects to isolated skin cell cultures. By taking out the complex variable of individual human immune response and using controlled in vitro cell models instead, the screening process achieves greater scientific accuracy and reproducibility. The method measures lipid mediator production in isolated keratinocytes or other skin cells exposed to inflammatory stimuli and test ingredients, eliminating inter-individual variability while maintaining biological relevance.
Data Source
AI summary
Compositions and methods for treating inflamed skin with Pro-Resolution Pathway Stimulators that may be Inflammatory Metabolite Inhibitors, Pro-Resolving Activators, or combinations thereof, and a method for screening active ingredients for activity as Pro-Resolution Pathway Stimulators for incorporation into topical cosmetic products.